27
Participants
Start Date
November 5, 2019
Primary Completion Date
January 30, 2023
Study Completion Date
January 30, 2023
Axicabtagene Ciloleucel
A single infusion of CAR-transduced autologous T cells administered intravenously
Rituximab
Administered intravenously
Fludarabine
Administered according to package insert
Cyclophosphamide
Administered according to package insert
Columbia University Medical Center, New York Presbyterian Hospital, New York
Mayo Clinic Florida, Jacksonville
Vanderbilt University Medical Center, Nashville
Mayo Clinic, Rochester
Loyola University Medical Center, Maywood
University of Chicago Medical Center, Chicago
The University of Texas MD Anderson Cancer Center, Houston
St. David's South Austin Medical Center, Austin
Banner MD Anderson Cancer Center, Gilbert
UCLA Hematology/Oncology, Santa Monica
Stanford Cancer Institute, Palo Alto
Swedish Cancer Institute, Seattle
City of Hope National Medical Center, Duarte
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Kite, A Gilead Company
INDUSTRY